PHENYLBUTAZONE - Generic Drug Details

✉ Email this page to a colleague

What are the generic drug sources for phenylbutazone and what is the scope of patent protection?

Phenylbutazone is the generic ingredient in three branded drugs marketed by Sanofi Aventis Us, Novartis, Chartwell Rx, Ivax Pharms, Sun Pharm Industries, Watson Labs, and Fosun Pharma, and is included in eleven NDAs. Additional information is available in the individual branded drug profile pages.

There are nine drug master file entries for phenylbutazone.

Summary for PHENYLBUTAZONE

US Patents:	0
Tradenames:	3
Applicants:	7
NDAs:	11
Drug Master File Entries:	9
Raw Ingredient (Bulk) Api Vendors:	118
Clinical Trials:	1
Patent Applications:	6,882
DailyMed Link:	PHENYLBUTAZONE at DailyMed

Recent Clinical Trials for PHENYLBUTAZONE

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Fundação de Amparo à Pesquisa do Estado de São Paulo	Phase 4
Federal University of São Paulo	Phase 4

See all PHENYLBUTAZONE clinical trials

Medical Subject Heading (MeSH) Categories for PHENYLBUTAZONE

Anti-Inflammatory Agents, Non-Steroidal

Anatomical Therapeutic Chemical (ATC) Classes for PHENYLBUTAZONE

M01AA	Butylpyrazolidines
M01A	ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS
M01	ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
M	Musculo-skeletal system

M02AA	Antiinflammatory preparations, non-steroids for topical use
M02A	TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN
M02	TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN
M	Musculo-skeletal system

US Patents and Regulatory Information for PHENYLBUTAZONE

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Watson Labs	PHENYLBUTAZONE	phenylbutazone	TABLET;ORAL	086151-001	Approved Prior to Jan 1, 1982		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Ivax Pharms	PHENYLBUTAZONE	phenylbutazone	CAPSULE;ORAL	088218-001	Jun 24, 1983		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Fosun Pharma	PHENYLBUTAZONE	phenylbutazone	TABLET;ORAL	084339-001	Approved Prior to Jan 1, 1982		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.